Avience Biomedicals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Medical Equipment/Supplies/Accessories |

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Avience Biomedicals

DeciZen not available for IPO

10 Year X-Ray of Avience Biomedicals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24TTM
ROCE % 21.4%20.6%30.4%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.210.916.30
Sales YoY Gr.-7.6%48.9%-
Adj EPS 2.72.46.10
YoY Gr.--12.2%154.2%-
BVPS (₹) 10.612.418.50
Adj Net
Profit
0.70.82NAN
Cash Flow from Ops. -21.70.1-
Debt/CF from Ops. -1.31.5101.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA48.9%
Adj EPS NANANA154.2%
BVPSNANANA49%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24TTM
Return on
Equity %
25.722.839.10
Op. Profit
Mgn %
1213.119.5NAN
Net Profit
Mgn %
7.17.212.2NAN
Debt to
Equity
0.90.71.3-
Working Cap
Days
02012240
Cash Conv.
Cycle
01301130

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Avience Biomedicals Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Avience Biomedicals:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Avience Biomedicals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales10.1510.9216.26
Operating Expenses 8.939.4913.08
Manufacturing Costs0.140.130.09
Material Costs7.517.7810.65
Employee Cost 0.490.691.02
Other Costs 0.790.901.33
Operating Profit 1.221.433.17
Operating Profit Margin (%) 12.0%13.1%19.5%
Other Income 00.010.38
Interest 0.160.270.44
Depreciation 0.090.200.44
Exceptional Items 000
Profit Before Tax 0.970.962.68
Tax 0.250.180.69
Profit After Tax 0.720.782
PAT Margin (%) 7.1%7.2%12.3%
Adjusted EPS (₹)2.72.46.1
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 2.794.086.07
Share Capital 2.033.283.28
Reserves 0.760.792.79
Minority Interest000
Debt2.492.647.35
Long Term Debt0.170.151.27
Short Term Debt2.322.496.08
Trade Payables0.231.274.19
Others Liabilities 0.582.048.01
Total Liabilities 6.1010.0225.63

Fixed Assets

Gross Block1.272.837.55
Accumulated Depreciation0.100.310.74
Net Fixed Assets1.172.526.82
CWIP 000.03
Investments 005.73
Inventories1.473.547.86
Trade Receivables2.531.702.42
Cash Equivalents 0.020.400.20
Others Assets0.911.862.57
Total Assets 6.1010.0225.63

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity -1.961.740.08
PBT 0.970.962.68
Adjustment 0.250.470.79
Changes in Working Capital -3.030.48-3.28
Tax Paid -0.16-0.17-0.12
Cash Flow From Investing Activity -0.89-1.94-4.12
Capex -0.87-1.69-3.94
Net Investments -0.02-0.25-0.20
Others 000.01
Cash Flow From Financing Activity 2.790.433.80
Net Proceeds from Shares 1.020.500
Net Proceeds from Borrowing 000
Interest Paid -0.15-0.24-0.35
Dividend Paid 000
Others 1.910.174.15
Net Cash Flow -0.060.24-0.24
PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)25.7122.7939.33
ROCE (%)21.3520.5530.36
Asset Turnover Ratio1.661.360.91
PAT to CFO Conversion(x)-2.722.230.04
Working Capital Days
Receivable Days917146
Inventory Days5384128
Payable Days113594

Avience Biomedicals Ltd Stock News

Avience Biomedicals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Avience Biomedicals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Avience Biomedicals stood at ₹0.00.
The latest P/E ratio of Avience Biomedicals as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Avience Biomedicals as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Avience Biomedicals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Avience Biomedicals is ₹0.00 ( Cr.) .

About Avience Biomedicals Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...